GAMMA Investing’s Zenas BioPharma ZBIO Stock Holding History

GAMMA Investing’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.01K	Buy	297 +102	+52%	+$3.14K	﹤0.01%	3466
2026 Q2	$4.95K	Sell	195 -50	-20%	-$994	﹤0.01%	3474
2026 Q1	$4.79K	Buy	245 +66	+37%	+$1.48K	﹤0.01%	3376
2025 Q4	$6.5K	Sell	179 -4	-2%	-$132	﹤0.01%	3168
2025 Q3	$4.06K	Buy	183 +104	+132%	+$1.69K	﹤0.01%	3253
2025 Q2	$766	Buy	79 +38	+93%	+$370	﹤0.01%	3584
2025 Q1	$324	Buy	+41	New	+$321	﹤0.01%	3734

Other funds holding ZBIO

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's ZBIO Position: Q3 2026 in Review

GAMMA Investing increased its Zenas BioPharma (ZBIO) stake by 52% in Q3 2026, buying an estimated $3.14K and bringing the position to 297 shares worth $8.01K. The position accounts for ﹤0.01% of the portfolio, ranked #3466.

GAMMA Investing first reported a position in ZBIO in Q1 2025 and has held it in 7 quarters since. 3 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.

GAMMA Investing held 297 shares of Zenas BioPharma worth $8.01K as of Q3 2026.
GAMMA Investing bought 102 Zenas BioPharma shares in Q3 2026, an estimated $3.14K.
Zenas BioPharma made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3466 holding.
GAMMA Investing first reported a position in Zenas BioPharma in Q1 2025 and has held it in 7 quarters since.
3 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.